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Purpose: To develop a simple, rapid and selective method for the spectrophotometric determination of 
cefadroxil and ceftriaxone using 1, 2- napthaquinone-4- sulfonic acid sodium. 
Methods: The method was based on the derivatization of cefadroxil and ceftriaxone with 1, 2- 
naphthaquinone-4- sulfonic acid sodium in alkaline medium to yield orange-colored products.                                                                     
Results: The reaction products of cefadroxil and ceftriaxone at their respective λ max of 475 and 480 
nm showed linearity in the concentration range of 10 - 100 and 25 - 175 µg/ml, respectively. Relative 
standard deviations of 0.82 % for cefadroxil and 0.95 % for ceftriaxone were obtained. Recoveries of 
cefadroxil tablets and ceftriaxone injection were in the range of 100.66 ± 0.98 and 99.38 ± 0.84 %, 
respectively. 
Conclusion: Recovery studies gave satisfactory results indicating that none of the major 
additives/excipients interfered with the assay method. Therefore, the proposed method is simple, rapid, 
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INTRODUCTION 
 




It is a first generation cephalosporin 
antibacterial drug that is the para-hydroxy 
derivative of cefalexin, and is used in the 
treatment of mild to moderate susceptible 
infections. It is a broad spectrum bactericidal 
antibiotic that is effective against many Gram-
positive and Gram-negative bacteria, 
including Staphylococcus aureus, Strepto-
coccus pneumoniae, Streptococcus 
piogenes, Moraxella catarrhalis, Escherichia 
coli, Klebsiella and Proteus mirabilis [1]. 
 
A wide variety of analytical methods have 
been reported for the determination of CFL in 
pure form, in pharmaceutical preparations 
and in biological fluids. These methods 
mainly involve spectrophotometry [2], atomic 
absorption spectrophotometry [3], fluorometry 
[4],
 
chemiluminescence [5], polarography [6], 
high performance liquid chromatography [7], 
and capillary electrophoresis [8]. CFL and 
cefotaxime have been determined by flow 




Some methods have been developed for the 
simultaneous determination of CFL when 
combined with other drugs in various dosage 
forms. CFL and cefotaxime in binary mixtures 
have been estimated by derivative 
spectrophotometry [10]. CFL and cephalexin 
in combination have been determined 
simultaneously by coupling technique of 
synchronous fluorimetry and H-point standard 
addition methods [11]. Similarly, CFL and 
cephalexin have also been determined by 
HPLC method [12] while 
 
CFL and cefuroxime  
determined 
 
in urine by measuring their first-
derivative amplitude in 0.1N sodium 
hydroxide at 292.5 and 267.3 nm, 
respectively. [13].  
 
Ceftriaxone (CFX) is (6R,7R)-7-[[(2Z)-(2-
amino-4-thiazolyl)(methoxyamino)-acetyl] 





It is a cephalosporin 
beta-lactum antibiotic used in the treatment of 
bacterial infections caused by susceptible, 
usually Gram-positive organisms. The 
bactericidal activities of CFX result from the 
inhibition of cell wall synthesis and are 
mediated through CFX binding to penicillin 
binding proteins (PBPs). It inhibits 
mucopeptide synthesis in the bacterial cell 
wall. The beta lactam moiety of CFX binds to 
caboxypeptidase, endopeptidase and 
transpeptidase in the bacterial cytoplasmic 
membrane. These enzymes are involved in 
cell wall synthesis and cell division. The 
binding of CFX to these peptidases results in 
the formation of defective cell walls and cell 
death [15]. 
  
The monographs for CFX in USP [16] and BP 
[17] describe an HPLC method for the 
estimation of the drug in pharmaceutical 
formulation. Various methods have been 
developed for CFX determination using 
HPTLC [18] and spectrophotometry [19]. 
Simple liquid chromatographic method for the 
analysis of the blood/brain barrier 
permeability characteristics of ceftriaxone in 
an experimental rabbit meningitis model has 
also been carried out using lignocaine as 
internal standard [20].   
 
1, 2-naphthoquinone-4-sulphonate (NQS) 
has been used as a chromogenic reagent for 
the colorimetric determination of many 
pharmaceutical amines [21- 23]. However, 
the reaction of NQS with CFL and CFX has, 
to the best of our knowledge, not been 
investigated. The present study describes the 
evaluation of NQS as a chromogenic reagent 
in the development of a simple and rapid 
colorimetric method for the determination of 
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A Shimadzu UV-visible spectrophotometer 
model 1800, with 1 cm matched quartz cells, 
was used for absorbance measurements. 
Systonics electronic balance (Shimadzu BL-
220H) was used for weighing the samples. 
 
Reagents and solutions 
 
All the chemicals employed were of analytical 
grade and high-purified water was used 
throughout. Ceftriaxone powder (pure 
sample) was received as a gift from Strides 
Arcolab Limited, Bangalore, India 
while cefadroxil was also provided free of 
charge by Torrent Pharmaceuticals Ltd, Dist. 
Mehsana, India. 
 
1, 2-Naphthoquinone-4-sulphonate (NQS) 
0.5 %w/v 
 
0.5 g of NQS (Loba Chemie Pvt. Ltd, 
Mumbai, India) was weighed  and transferred 
into a 100 ml calibrated flask, dissolved in 5 
ml distilled water, and made up to the mark 
with distilled water to obtain a solution of 0.5 
%w/v. The solution was freshly prepared and 
protected from light during use. 
 
Sodium hydroxide solution (0.01 M)                                                                                                              
 
Sodium hydroxide (0.2 g) was weighed   and 
transferred into a 500 ml volumetric flask and 
made up to the mark with distilled water. 
 
Standard solutions  
 
CFL and CFX stock solutions (1000 µg/ml) 
were prepared separately by dissolving 0.1 g 
of each drug in 100 ml of distilled water. 
Working solutions of the drug were prepared 
by dilution of the stock solution. The 
commercial tablet of CFL used in the 
determination was Droxyl, with a labelled 
strength of 500 mg, and manufactured by 
Torrent Pharmaceuticals Limited, Mehsana, 
India while the injection form of CFX used in 
the determination was Extacef-i with a 
labelled quantity of 1 g on the vial and 
manufactured by Nitin Life Sciences Limited, 
Sirmour, India. 
 
Optimization of reaction variables 
  
Effect of NQS concentration  
 
The effect of NQS was studied by varying 
NQS concentrations (Scheme 1). The 
absorbance of the reaction solution increased 
as NQS concentration increased, and the 
highest absorption intensity was attained at 
NQS concentration of 0.25 % w/v. Further 
experiments were carried out using 0.5 %.  
 
Effect of alkalinity  
 
To generate nucleophiles from CFL/CFX and 
activate nucleophilic substitution reactions, 
alkaline medium is necessary. The different 
inorganic bases tested include sodium 
hydroxide, disodium hydrogen phosphate, 
and sodium bicarbonate. They were all 
prepared as aqueous solutions in the 
concentration range of 0.01 - 0.05N.  
 
Preparation of calibration curve 
 
Standard solutions of CFL and CFX in water, 
having final concentrations in the range of 10 
- 100 µg/ml and 25 - 175 µg/ml, respectively, 
were transferred into a series of 10 ml 
volumetric flasks. To each of these solutions, 
1 ml of 0.01M sodium hydroxide was added, 
followed by 1 ml of 0.5 % NQS. The mixture 
was then gently shaken until the appearance 
of orange colour. The contents were diluted 
to 10 ml with distilled water. The absorbance 
of each solution was measured at 475 nm 
and 480nm for CFL and CFX, respectively, 
against the reagent blank prepared in the 
same manner, without the analyte. The 
calibration plots and absorption spectra are 
represented in the Figs 1 and 2, respectively. 
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Fig 1: Calibration plots of CFL (●) and CFX 
(○) with concentration ranges of 10 - 100 and 
25 - 175 µg/ml, respectively 
Fig 2: Absorption spectra of NQS - CFL (●) and 
NQS - CFX (○), against reagent blank 
 
 





Twenty tablets were weighed, crushed and 
their contents mixed thoroughly. An 
accurately weighed portion of the powder, 
equivalent to the labelled strength (100 mg) 
of CFL, was taken into a 100 ml volumetric 
flask containing about 75 ml of distilled water. 
This was shaken thoroughly for about 5 - 10 
min and filtered with Whatman filter paper no. 
1 (porosity 11µ) to remove insoluble matter. 
The filter paper was rinsed severally and the 
filtrate diluted to mark with distilled water to 
prepare 1000 µg/ml solution. An aliquot of 
this solution was diluted with water to obtain 
a concentration of 50 µg/ml. To the sample 
solution (0.5ml), 1 ml of 0.01M sodium 
hydroxide was added, followed by 1 ml of 0.5 
% NQS. The mixture was then gently shaken 
until the appearance of orange colour. The 





An appropriate amount of CFX was dissolved 
in water for injection to prepare 1000 µg/ml 
solution. An aliquot of this solution was 
diluted with water to obtain a concentration of 
150 µg/ml. To the sample solution (1.5 ml), 1 
ml of 0.01M sodium hydroxide was added, 
followed by 1 ml of 0.5 % NQS. The mixture 
was then gently shaken until the appearance 
of orange colour. The contents were diluted 




Series of standard solutions of CFL (0.1 to 
1.0 ml) and CFX (0.25 - 1.75 ml) were taken 
in individual standard flasks. To each 
standard flask, 1 ml of 0.01M sodium 
hydroxide and 1 ml of 0.5 % NQS were 
added. The mixtures were then shaken until 
the appearance of orange colour. Their 
absorbance values were measured at λ max 
of 475 and 480 nm for CFL and CFX, 
respectively, against a blank similarly 
prepared by substituting the drug solution 
with water. The concentration of CFL and 
CFX in each standard flask was obtained by 
interpolating the corresponding absorbance 
value of the product from Beer’s plot of 




The limits of Beer’s law, the molar 
absorptivity and the Sandell’s sensitivity 
values for CFL and CFX were evaluated and 
are given in Table 1. Regression analyses of  
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       Table 1: Optical parameters (n = 6) 
 
Values  
Parameter Cefadroxil (CFL) Ceftriaxone (CFX) 
λmax (nm) 475 nm 480 nm 
Beer’s law limits (µg/ml) 10-100 25-175 




 0.295 x 10
4
 
Correlation coefficient (R) 0.993 0.995 
Sandell’s sensitivity (ng cm
-2
) 0.079 0.1879 
Regression equation Y = 0.009X + 0.011 Y = 0.005X + 0.010 
Slope, b 0.009 0.004 
Intercept, c 0.011 0.010 
Relative standard deviation (%) 0.82 0.95 
% Range of error (95% confidence limits) 0.89 0.92 
Limit of detection (µg/ml) 10 25 
Limit of quantification(µg/ml) 100 125 
 
Note: Y = bX + c, where X is the concentration of drug in µg/ml 
 
 
the Beer plots at their respective λmax values 
revealed a good correlation.  
 
Validation of the method 
 
The validity of the methods for the assay of 
CFL and CFX were examined by determining 
the precision and accuracy. These were 
determined by analyzing six replicates of the 
drug within the Beer’s law limits. To study the 
accuracy of the methods, recovery studies 
were carried out by the standard addition 
method. For this, known quantities of pure 
CFL and CFX were mixed with definite 
amounts of pre-analyzed formulations and 
the mixtures were analyzed as before. The 
total amount of the drug was then 
determined; the amount of the added drug 
was calculated by difference and the results 




The precision of the proposed methods was 
ascertained by actual determination of six 
replicates of a fixed concentration of each 
drug within the Beer’s law range and 
determining the absorbance in each case by 





To determine the accuracy of the proposed 
method, recovery studies were carried out by 
taking different amounts (80, 100 and 120 %) 
of bulk samples of CFL and CFX within the 
linearity range which were then added to the 
pre-analyzed formulation of concentrations 




To ascertain the ruggedness of the methods, 
four replicate determinations at different 
concentration levels of the drugs were carried 
out. The within-day and inter-day RSD values 
were determined. The values for different 
concentrations of drugs obtained from the 




The test method was based on the reaction 
between NQS and cephalosporin molecules. 
The NQS reacted with cephalosporin at the 
free NH2 group as represented in Scheme 1. 
The reaction was carried out in alkaline 
medium and best results were obtained with 
sodium hydroxide. With other bases, either 
precipitation of a white colloid occurred upon 
diluting the reaction solution with organic 
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solvent, or high blank readings, non-
reproducible results, and/or weak sensitivity, 
were observed. Studies for optimization of 
sodium hydroxide concentration revealed that 
the optimum concentration was 0.01 M.  
 
Table 2: Analysis, recovery and ruggedness data 
(± SEM, n = 6) for CFL tablets and CFX injection 














































The reagent blank had negligible absorbance 
in the range used for the detection of the 
cephalosporins.  As Fig 1 shows, Beer’s law 
was obeyed in the range of 10 - 100 µg/ml for 
CFL and 25 - 175 µg/ml for CFX. Plots of 
absorbance versus concentration showed the 
intercept values of about 0.011 and 0.010 for 
CFL and CFX, respectively; the plots are 
described by the regression equation, Y = bX 
+ c (where Y is the absorbance of a 1 cm 
layer, b is the slope, c is the intercept and X 
is the concentration of the drug in µg/ml) 
obtained by the least-squares method. The 
average percent recoveries obtained were 
quantitative, indicating good accuracy of the 
methods. The low values of the relative 
standard deviation (R.S.D.) indicate good 
precision of the methods. The data indicate 





Derivatisation using NQS has attracted 
considerable attention for the quantitative 
analysis of many pharmaceutically active 
compounds. In the present investigation, 
NQS formed a coloured complex with CFL 
and CFX in alkaline medium and their 
absorbance maxima were 475 and 480 nm, 
respectively. Because of the presence of 
amine as a chromophoric group in CFL and 
CFX molecules, derivatization of these 
compounds was attempted in the present 
study for the development of a colorimetric 
method for their determination. NQS has 
been used as a chromogenic and fluorogenic 
reagent for primary and secondary amines 
[20]. Therefore, the present study was 
devoted to explore NQS as a derivatizing 
reagent in the development of a colorimetric 
method for the determination of CFL and 
CFX in pharmaceutical dosage forms. 
Optimisation of the spectrophotometric 
conditions was intended to take into account 
the various goals of method development. 
Analytical conditions were optimised via a 
number of preliminary experiments. The 
effect of NQS concentration was studied and 
it was found that 0.5 % gave good 
absorbance values, and so further 
experiments were carried out using 0.5 % 
NQS. To generate nucleophiles from CFL 
and CFX, and activate the nucleophilic 
substitution reactions, alkaline medium was 
necessary. Though various inorganic bases 
were tested such as sodium hydroxide, 
disodium hydrogen phosphate, and sodium 
bicarbonate, all were prepared as aqueous 
solutions in a concentration range of 0.01 - 
0.05N. The best results were obtained with 
sodium hydroxide in a concentration of 0.01 
N solution (1 ml).  
 
Under optimum conditions, the reaction 
between CFL/CFX and NQS was completed 
within 2 min at room temperature, and the 
absorbance remained unchanged after 
standing for up to 40 min. The effect of time 
on the stability of the chromogen was studied 
by following the absorption intensity of the  
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Scheme 1: Proposed reaction mechanism for the 
formation of coloured species 
 
reaction solution (after dilution) at different 
time intervals. It was found that the 
absorbance of the chromogen remained 
stable for at least 4 h. This allowed the 
processing of large batches of samples and 
their measurement with convenience. In 
addition to convenience, the methods would 
also facilitate their applicability to a large 




The reagents used in the proposed methods 
are low-cost, readily available and the 
procedures do not involve any critical 
reaction conditions or tedious sample 
preparation. Furthermore, the methods are 
free from interference by common additives 
and excipients. The wide applicability of the 
new procedures in routine quality control was 
well established by the assay of the 
cephalosporins (CFL and CFX) in pure form 
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